Observational analysis uncovered similar apheresis rates for multiple myeloma patients, highlighting access disparities linked to race and socioeconomic status.
Key Points
The study found comparable apheresis rates across racial groups, indicating reduced disparity in CAR-T access for multiple myeloma.
Analysis of 271 referrals revealed that distance, income, and insurance did not significantly affect access to CAR-T therapy.
Data was collected over three years, focusing on how social determinants of health influence eligibility for leukapheresis.
The findings suggest the need for further national research into the social factors impacting CAR-T therapy access for minorities.